Thursday, April 14, 2022

Early Ivermectin Use Proven Ineffective Against Prevention of Serious Illness Resulting in Hospitalization Due to COVID ...

I've been meaning to post this for a while, but was distracted by other stuff :)

Peer-reviewed in the New England Journal of Medicine,  the study was a randomized, double-blind, placebo-controlled study of 3,515 COVID-positive participants in Brazil.

679 patients received Ivermectin, 679 patients received placebo, and 2,157 received other intervention.

The primary endpoint of the study was serious illness resulting in hospital admission.

Of those receiving Ivermectin, 14.7% resulted in hospital admission, and 16% of those receiving placebo resulted in hospital admission.

The  1% difference in Ivermectin treated versus placebo is considered not statistically significant or clinically meaningful - typically, when the difference is within a percent or two, it is considered likely due to other variables (i.e., other comorbid conditions, medications to treat those conditions, lifestyle factors such as smoking or vaping, etc).

The conclusion was: 

"Treatment with ivermectin did not result in a lower incidence of medical admission to a hospital due to progression of Covid-19 or of prolonged emergency department observation among outpatients with an early diagnosis of Covid-19. 
(Funded by FastGrants and the Rainwater Charitable Foundation; TOGETHER number, NCT04727424. opens in new tab.)"

End of. 

You would think that Trumpers would start to question their sources, now, but they don't, and if Trump et al told them to drink gasoline to cure themselves, they wouldn't, but they will do whatever their political leaders tell them to versus actual medical doctors.  

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.